How to Fix a Drug Scandal

Erin Lee Carr’s How to Fix a Drug Scandal: The True Crime Docuseries That Exposed a Legal Nightmare

Netflix’s How to Fix a Drug Scandal (2020) isn’t just another true crime binge—it’s a four-part deep dive into one of the most shocking forensic lab scandals in U.S. history. Directed by Erin Lee Carr, the series unpacks the cases of two Massachusetts chemists, Annie Dookhan and Sonja Farak, whose misconduct at state drug labs led to tens of thousands of wrongful convictions. latestnetflix.com's read is that with a cast featuring journalists, lawyers, and the chemists themselves, the docuseries blends legal drama with personal tragedy, all while questioning the systemic failures that allowed the scandal to spiral.

The Scandal That Rocked Massachusetts

At the heart of How to Fix a Drug Scandal are two women whose actions had devastating consequences. Annie Dookhan, a former chemist at the Hinton State Laboratory Institute, was caught falsifying drug tests, tampering with evidence, and even lying under oath—leading to the dismissal of over 21,000 convictions . Sonja Farak, another state chemist, was later exposed for stealing and using the very drugs she was supposed to be testing, further complicating an already catastrophic legal fallout.

The series doesn’t just rehash the crimes; it examines the human cost. Interviews with defense attorneys, prosecutors, and wrongfully convicted individuals reveal a justice system ill-equipped to handle such widespread corruption. One of the most chilling moments comes from Luke Ryan, a lawyer who fought to overturn convictions tied to Dookhan’s misconduct, highlighting how easily forensic fraud can destroy lives .

Erin Lee Carr’s Approach: Style and Controversy

Carr, known for her unflinching documentaries like Mommy Dead and Dearest and I Love You, Now Die, brings her signature investigative rigor to How to Fix a Drug Scandal. The series combines archival footage, courtroom recordings, and candid interviews to create a tense, almost thriller-like narrative. But unlike traditional true crime, Carr doesn’t just sensationalize—she critiques. The docuseries questions why it took years for the scandal to be fully exposed and why systemic safeguards failed so spectacularly.

Some viewers have noted that the series leans heavily on the perspectives of journalists and legal experts, leaving the chemists themselves—Dookhan and Farak—with less screen time. Dookhan, in particular, is portrayed as a complex figure, with Carr avoiding a straightforward villain narrative. Instead, the series suggests that institutional pressure and personal ambition played roles in her downfall .

Reception and Legacy

Since its April 2020 release, How to Fix a Drug Scandal has earned mixed but engaged reactions. Critics praise its thorough reporting and Carr’s ability to make dense legal proceedings gripping, though some argue it could have delved deeper into the personal lives of Dookhan and Farak . With a 6.4/10 rating on SensCritique (based on 70 votes), it’s clear the series resonated more as a cautionary tale than a traditional entertainment piece .

Netflix’s marketing leaned into the scandal’s shock value, with trailers emphasizing the sheer scale of the wrongful convictions . But beyond the headlines, the series serves as a stark reminder of how easily forensic science can be manipulated—and how difficult it is to fix the damage once it’s done.

What’s Next?

As of now, there’s no confirmation of a second season, and the evidence doesn’t suggest any follow-up projects in the works. But given Carr’s track record, it wouldn’t be surprising if she revisited the fallout of the Massachusetts drug lab scandal in future work. For now, How to Fix a Drug Scandal stands as a chilling case study in institutional failure—and a warning about the fragility of justice.